Biopharmaceuticals
Licensing
News Release - January 24, 2019
Merck KGaA, Darmstadt, Germany, Grants Exclusive License to Vertex for Two DNA Damage Response Inhibitors
Source: Merck KGaA
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.